2018

/Tag:2018

Oramed to Present at the CODHy 6th World Congress on Diabetes, Obesity and Hypertension

JERUSALEM, Feb. 20, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming CODHy Conference, The 6th World Congress on Controversies [...]

2018-05-30T17:03:59+00:00 Categories: Press Releases|Tags: |

Oramed to Present at BIO CEO Investor Conference

JERUSALEM, Feb. 6, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming BIO CEO & Investor Conference, taking place February 12-13, [...]

2018-05-30T17:03:59+00:00 Categories: Press Releases|Tags: |

Oramed Pharmaceuticals’ CEO Issues Letter to Shareholders

JERUSALEM, Jan. 19, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com) Dear Shareholders, All the hard work and dedication in 2017 has successfully positioned Oramed to initiate a U.S. based multicenter 90-day treatment study under a FDA IND focused on the lowering of [...]

2018-05-30T17:03:59+00:00 Categories: Press Releases|Tags: |